Machine Learning

The new Molecule Search platform unifies chemical and biological data, aiming to accelerate drug discovery in an increasingly competitive, AI-driven market.

As COVID revenues fall, BioNTech bets its future on a robust oncology pipeline. The upcoming Q1 2026 report will reveal the financial health of this pivot.

Sion Power's new 500 Wh/kg lithium-metal cells promise to revolutionize drone warfare, dramatically extending flight times and boosting US supply chain security.

Celebrating its 1,000th fellow, a visionary program empowers women in STEM to drive change, from cancer tech to national policy, in their home countries.

A regional bank found itself in a brand collision caused by AI. Its decision to rebrand reveals a new challenge for businesses in the digital age.

Captium's expanded platform integrations stream vital data from existing fire trucks, creating a smarter, safer fireground without costly fleet replacements.

Following its rebrand, AI firm Tenarai appoints GlobalLogic visionary Shashank Samant to its board, a strategic move to dominate enterprise AI deployment.

Obsidian Therapeutics will unveil pivotal Phase 2 data on OBX-115, an engineered cell therapy that may offer a safer, more potent weapon against melanoma.

New preclinical data for InnoCare's ICP-B794 reveals a wider safety window and power to overcome drug resistance, positioning it as a top contender.

Backed by Avesi Partners, Mosaic Consulting Group launches a new SAP practice, leveraging AI and veteran leadership to redefine enterprise cloud adoption.

UK biotech Promatix presented a new AI-driven platform at AACR 2026 that finds thousands of new cancer targets, promising safer, more precise 'smart bomb' drugs.

Sonata Software's new AWS status validates its AI-first approach, positioning it as a key player in the booming cloud modernization market.

GTT unveils its 2026 strategy, leveraging a new AI factory to deliver a unified platform for secure, intelligent global enterprise connectivity.

Biotech firm Northwest Biotherapeutics is opening a private clinic to speed up cancer therapy access, a strategic move to control its supply chain.

Digital Brands Group launches AVO apparel with Vanderbilt, tapping the NIL market. But can a struggling company score a win in the big leagues of college sports?

The Texas hospital is ditching manual spreadsheets for an automated system, aiming to free up doctors' time, ensure fairer workloads, and improve patient care.

A new AI-driven platform moves beyond static reports, offering continuous genomic updates to give cancer patients access to the latest treatment options.

The fast-growing Pilates franchise partners with KSM, using data-driven marketing to open 70 studios and compete in the booming boutique fitness market.

AI promises to transform drug discovery, but billions in investment are at risk. A new report reveals why the real bottleneck isn't tech, but data itself.

With a new legal chief experienced in FDA clearance, Formedics signals an aggressive push to navigate regulatory hurdles and dominate HCP engagement.